Applied Molecular Transport Inc. (AMTI)

0.2040 -0.0040 (-1.92%) At close: 04:00PM EDT

Applied Molecular Transport Inc.

450 East Jamie Court
South San Francisco, CA 94080
United States
650 392 0420
https://www.appliedmt.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 13

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Shawn M. Cross	CEO & Chairman	679.78k	N/A	1968
Dr. Tahir Mahmood Ph.D.	Co-Founder & Director	870.29k	N/A	1975
Mr. Brandon Hants	Chief Financial Officer	N/A	N/A	1977
Mr. Andrew H. Chang	Head of Investor Relations & Corp. Communications	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Corporate Governance

Applied Molecular Transport Inc.’s ISS Governance QualityScore as of September 1, 2023 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.